Generic placeholder image

Recent Patents on Biotechnology


ISSN (Print): 1872-2083
ISSN (Online): 2212-4012


Meet the Editorial Board Member

Author(s): Alexsandro S. Galdino

Volume 17, Issue 1, 2023

Published on: 12 December, 2022

Page: [2 - 2] Pages: 1

DOI: 10.2174/187220831701221212163054

Candia-Puma MA, Machaca-Luque LY, Roque-Pumahuanca BM, et al. Accuracy of diagnostic tests for the detection of Chagas disease: A systematic review and meta-analysis. Diagnostics 2022; 12(11): 2752.
Souza M, Machado J, Da Silva J, et al. Rational design and evaluation of the recombinant multiepitope protein for serodiagnosis of Rubella. Curr Pharm Biotechnol 2022; 23(8): 1094-100.
Pereira DFS, Ribeiro HS, Gonçalves AAM, et al. Rhipicephalus microplus: An overview of vaccine antigens against the cattle tick. Ticks Tick Borne Dis 2022; 13(1)101828
Ribeiro HS, Pereira DFS, Melo-Junior O, et al. Vaccine approaches applied to controlling dog ticks. Ticks Tick Borne Dis 2021; 12(3)101631
Dos Santos M, Ferreira AVF, Da Silva JO, et al. Patents related to pathogenic human coronaviruses. Recent Pat Biotechnol 2021; 15(1): 12-24.
Ferreira AVF, Silva FF, Silva AAM, et al. Recent patents on the industrial application of alpha-amylases. Recent Pat Biotechnol 2020; 14(4): 251-68.
Pires MEE, Parreira AG, Silva TNL, et al. Recent patents on impact of lipopeptide on the biofilm formation onto titanium and stainless steel surfaces. Recent Pat Biotechnol 2020; 14(1): 49-62.
Machado JM, Costa LE, Dias DS, et al. Diagnostic markers selected by immunoproteomics and phage display applied for the serodiagnosis of canine leishmaniosis. Res Vet Sci 2019; 126: 4-8.
Giunchetti RC, Silveira P, Resende LA, et al. das Dores Moreira N, Mathias FAS, Cardoso JMDO, Coura-Vital W, Galdino AS, Viana KF, Martins-Filho OA, Silveira-Lemos DD, Dutra WO, Reis AB. Canine visceral Leishmaniasis biomarkers and their employment in vaccines. Vet Parasitol 2019; 271: 87-97.
Ribeiro PAF, Dias DS, Lage DP, et al. Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection. Mol Immunol 2019; 106: 108-18.

© 2024 Bentham Science Publishers | Privacy Policy